Jianying Gu

T cell receptor-engineered T cells for hepatocellular carcinoma: next steps and future perspectives

Abstract Hepatocellular carcinoma (HCC) accounts for a substantial proportion of cancer mortality worldwide, and clinical outcomes remain poor for patients with advanced disease. T cell receptor-engineered T cells (TCR-T) represent an attractive immunotherapeutic modality because...